Role of cholesterol and lipid organization in disease

Nature

Volumn 438, Issue 7068, 2005, Pages 612-621

  Maxfield, Frederick R ^a   Tabas, Ira ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Departments of Medicine Cell Biology and Physiology and Cellular Biophysics Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; CELL MEMBRANES; DISEASE CONTROL; LIPIDS; METABOLISM;

BIOLOGICAL FUNCTIONS; LIPID METABOLISM; TANGIER DISEASE;

CHOLESTEROL;

CHOLESTEROL; LIPID;

DISEASE;

ATHEROSCLEROSIS; HUMAN; LIPID MEMBRANE; LIPID METABOLISM; MEMBRANE TRANSPORT; MOLECULAR DYNAMICS; NIEMANN PICK DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TANGIER DISEASE;

EID: 28444479505     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature04399     Document Type: Review

References (100)

1. Lee, A. G. How lipids affect the activities of integral membrane proteins. Biochim. Biophys. Acta 1666, 62-87 (2004).
2. Simons, K. & Vaz, W. L. Model systems, lipid rafts, and cell membranes. Annu. Rev. Biophys. Biomol. Struct. 33, 269-295 (2004).
3. Mukherjee, S. & Maxfield, F. R. Membrane domains. Annu. Rev. Cell Dev. Biol. 20, 839-866 (2004).
4. Holowka, D. et al. Lipid segregation and IgE receptor signaling: A decade of progress. Biochim. Biophys. Acta doi:10.1016/j.bbamcr.2005.06.007 (2005).
5. Goldstein, J. L. & Brown, M. S. Molecular medicine. The cholesterol quartet. Science 292, 1310-1312 (2001).
6. Anitschkow, N. & Chalatow, S. Über experimentelle cholesterinsteatose und ihre bedeutung für die einiger pathologischer prozesse. Zentralbl. Allg. Pathol. 24, 1-9 (1913).
7. Wolozin, B. Cholesterol, statins and dementia. Curr. Opin. Lipidol. 15, 667-672 (2004).
8. Simons, K. & Ikonen, E. Functional rafts in cell membranes. Nature 387, 569-572 (1997).
9. Munro, S. Lipid rafts: elusive or illusive? Cell 115, 377-388 (2003).
10. Sprong, H., van der Sluijs, P. & van Meer, G. How proteins move lipids and lipids move proteins. Nature Rev. Mol. Cell Biol. 2, 504-513 (2001).
11. Schroeder, R. J., Ahmed, S. N., Zhu, Y., London, E. & Brown, D. A. Cholesterol and sphingolipid enhance the Triton X-100 insolubility of glycosylphosphatidylinositol-anchored proteins by promoting the formation of detergent-insoluble ordered membrane domains. J. Biol. Chem. 273, 1150-1157 (1998).
12. Resh, M. D. Membrane targeting of lipid modified signal transduction proteins. Subcell. Biochem. 37, 217-232 (2004).
13. Wang, T. Y., Leventis, R. & Silvius, J. R. Partitioning of lipidated peptide sequences into liquid-ordered lipid domains in model and biological membranes. Biochemistry 40, 13031-13040 (2001).
14. Melkonian, K. A., Ostermeyer, A. G., Chen, J. Z., Roth, M. G. & Brown, D. A. Role of lipid modifications in targeting proteins to detergent-resistant membrane rafts. Many raft proteins are acylated, while few are prenylated. J. Biol. Chem. 274, 3910-3917 (1999).
15. Bretscher, M. S. & Munro, S. Cholesterol and the Golgi apparatus. Science 261, 1280-1281 (1993).
16. Mitra, K., Ubarretxena-Belandia, I., Taguchi, T., Warren, G. & Engelman, D. M. Modulation of the bilayer thickness of exocytic pathway membranes by membrane proteins rather than cholesterol. Proc. Natl Acad. Sci. USA 101, 4083-4038 (2004).
17. Pierini, L. M. et al. Membrane lipid organization is critical for human neutrophil polarization. J. Biol. Chem. 278, 10831-10841 (2003).
18. Feramisco, J. D. et al. Intramembrane aspartic acid in SCAP protein governs cholesterol-induced conformational change. Proc. Natl Acad. Sci. USA 102, 3242-3247 (2005).
19. Hao, M. et al. Vesicular and non-vesicular sterol transport in living cells. The endocytic recycling compartment is a major sterol storage organelle. J. Biol. Chem. 277, 609-617 (2002).
20. Maxfield, F. R. & Wustner, D. Intracellular cholesterol transport. J. Clin. Invest. 110, 891-898 (2002).
21. Vainio, S. & Ikonen, E. Macrophage cholesterol transport: a critical player in foam cell formation. Ann. Med. 35, 146-155 (2003).
22. Soccio, R. E. & Breslow, J. L. Intracellular cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 24, 1150-1160 (2004).
23. Strauss, J. F., Kishida, T., Christenson, L. K., Fujimoto, T. & Hiroi, H. START domain proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol. Cell Endocrinol. 202, 59-65 (2003).
24. Wustner, D., Mondal, M., Tabas, I. & Maxfield, F. R. Direct observation of rapid internalization and intracellular transport of sterol by macrophage foam cells. Traffic 6, 396-412 (2005).
25. Sleat, D. E. et al. Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc. Natl Acad. Sci. USA 101, 5886-5891 (2004).
26. Carstea, E. et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science 277, 228-231 (1997).
27. Blanchette-Mackie, E. Intracellular cholesterol trafficking: role of the NPC1 protein. Biochim Biophys Acta 1486, 171-183 (2000).
28. Mukherjee, S. & Maxfield, F. R. Lipid and cholesterol trafficking in NPC. Biochim. Biophys. Acta 1685, 28-37 (2004).
29. Chang, T. Y., Chang, C. C. & Cheng, D. Acyl-coenzyme A:cholesterol acyltransferase. Annu. Rev. Biochem. 66, 613-638 (1997).
30. Yeaman, S. J. Hormone-sensitive lipase - new roles for an old enzyme. Biochem. J. 379, 11-22 (2004).
31. Tabas, I. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications J. Clin. Invest. 110, 905-911 (2002).
32. Zhang, Y. et al. Cholesterol is superior to 7-ketocholesterol or 7 alpha-hydroxycholesterol as an allosteric activator for acyl-coenzyme A:cholesterol acyltransferase 1. J. Biol. Chem. 278, 11642-11647 (2003).
33. Lange, Y., Ye, J. & Steck, T. L. How cholesterol homeostasis is regulated by plasma membrane cholesterol in excess of phospholipids. Proc. Natl Acad. Sci. USA 101, 11664-11667 (2004).
34. Brown, M. S. & Goldstein, J. L. A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc. Natl Acad. Sci. USA 96, 11041-11048 (1999).
35. Tall, A. R., Costet, P. & Wang, N. Regulation and mechanisms of macrophage cholesterol efflux. J. Clin. Invest. 110, 899-904 (2002).
36. Pohl, A., Devaux, P. F.& Herrmann, A. Function of prokaryotic and eukaryotic ABC proteins in lipid transport. Biochim. Biophys. Acta 1733, 29-52 (2005).
37. Fielding, C. J. & Fielding, P. E. Cellular cholesterol efflux. Biochim. Biophys. Acta 1533, 175-189 (2001).
38. Sun, Y. et al. Stearoyl-CoA desaturase inhibits ATP-binding cassette transporter A1-mediated cholesterol efflux and modulates membrane domain structure. J. Biol. Chem. 278, 5813-5820 (2003).
39. Wang, N. & Tall, A. R. Regulation and mechanisms of ATP-binding cassette transporter A1-mediated cellular cholesterol efflux. Arterioscler. Thromb. Vasc. Biol. 23, 1178-1184 (2003).
40. Schroepfer, G. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 80, 361-554 (2000).
41. Costet, P. et al. Retinoic acid receptor-mediated induction of ABCA1 in macrophages. Mol. Cell Biol. 23, 7756-7766 (2003).
42. Chawla, A., Repa, J. J., Evans, R. M. & Mangelsdorf, D. J. Nuclear receptors and lipid physiology: opening the X-files. Science 294, 1866-1870 (2001).
43. Oram, J. F. ATP-binding cassette transporter A1 and cholesterol trafficking. Curr. Opin. Lipidol. 13, 373-381 (2002).
44. Horton, J. D., Goldstein, J. L. & Brown, M. S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131 (2002).
45. Sampath, H. & Ntambi, J. M. Polyunsaturated fatty acid regulation of genes of lipid metabolism. Annu. Rev. Nutr. 25, 317-340 (2005).
46. Kolter, T. & Sandhoff, K. Principles of lysosomal membrane digestion-stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids. Annu. Rev. Cell Dev. Biol. 21, 81-103 (2004).
47. Kobayashi, T. et al. Late endosomal membranes rich in lysobisphosphatidic acid regulate cholesterol transport. Nature Cell Biol. 1, 113-118 (1999).
48. Sturley, S. L., Patterson, M. C., Balch, W. & Liscum, L. The pathophysiology and mechanisms of NP-C disease. Biochim. Biophys. Acta 1685, 83-87 (2004).
49. Friedland, N., Liou, H. L., Lobel, P. & Stock, A. M. Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease. Proc. Natl Acad. Sci. USA 100, 2512-2517 (2003).
50. Pagano, R. E. Endocytic trafficking of glycosphingolipids in sphingolipid storage diseases. Phil. Trans. R. Soc. Lond. B 358, 885-891 (2003).
51. Stefkova, J., Poledne, R. & Hubacek, J. A. ATP-binding cassette (ABC) transporters in human metabolism and diseases. Physiol. Res. 53, 235-243 (2004).
52. Williams, K. J. & Tabas, I. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15, 551-561 (1995).
53. Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685-1695 (2005).
54. Berliner, J. A., Subbanagounder, G., Leitinger, N., Watson, A. D. & Vora, D. Evidence for a role of phospholipid oxidation products in atherogenesis. Trends Cardiovasc. Med. 11, 142-147 (2001).
55. Glass, C. K. & Witztum, J. L. Atherosclerosis. The road ahead. Cell 104, 503-516 (2001).
56. Brown, M. S. & Goldstein, J. L. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 52, 223-261 (1983).
57. Kruth, H. S. et al. Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J. Biol. Chem. 280, 2352-2360 (2005).
58. Buton, X. et al. Unique cellular events occurring during the initial interaction of macrophages with matrix-retained or methylated aggregated low density lipoprotein (LDL). Prolonged cell-surface contact during which LDL-cholesteryl ester hydrolysis exceeds LDL protein degradation. J. Biol. Chem. 274, 32112-32121 (1999).
59. Sakr, S. W. et al. The uptake and degradation of matrix-bound lipoproteins by macrophages require an intact actin cytoskeleton, Rho family GTPases, and myosin ATPase activity. J. Biol. Chem. 276, 37649-37658 (2001).
60. Qin, C., Nagao, T., Grosheva, I., Maxfield, F. R. & Pierini, L. M. Elevated plasma membrane cholesterol content alters macrophage signaling and function. Arterioscler. Thromb. Vasc. Biol (in the press).
61. Gerrity, R. G. The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J. Pathol. 103, 181-190 (1981).
62. Tabas, I. Nonoxidative modifications of lipoproteins in atherogenesis. Annu. Rev. Nutr. 19, 123-139 (1999).
63. Suzuki, H. et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature 386, 292-296 (1997).
64. Febbraio, M., Hajjar, D. P. & Silverstein, R. L. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108, 785-791 (2001).
65. Moore, K. J. et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J. Clin. Invest. 115, 2192-2201 (2005).
66. Williams, K. J. & Fisher, E. A. Oxidation, lipoproteins, and atherosclerosis: which is wrong, the antioxidants or the theory? Curr. Opin. Clin. Nutr. Metab. Care 8, 139-146 (2005).
67. Twickler, T., Dallinga-Thie, G. M., Chapman, M. J. & Cohn, J. S. Remnant lipoproteins and atherosclerosis. Curr. Atheroscler. Rep. 7, 140-147 (2005).
68. Arai, S. et al. A role for the apoptosis inhibitory factor AIM/Spa/Api6 in atherosclerosis development. Cell Metabolism 1, 201-213 (2005).
69. Libby, P. & Clinton, S. K. The role of macrophages in atherosclerosis. Curr. Opin. Lipidol. 4, 355-363 (1993).
70. Abrams, J. Clinical practice. Chronic stable angina. N. Engl. J. Med 352, 2524-2533 (2005).
71. Aikawa, M. & Libby, P. The vulnerable atherosclerotic plaque: pathogenesis and therapeutic approach. Cardiovasc. Pathol. 13, 125-138 (2004).
72. Shah, P. K. Insights into the molecular mechanisms of plaque rupture and thrombosis. Indian Heart J. 57, 21-30 (2005).
73. Corti, R., Hutter, R., Badimon, J. J. & Fuster, V. Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J. Thromb. Thrombolysis 17, 35-44 (2004).
74. Virmani, R., Burke, A. P., Kolodgie, F. D. & Farb, A. Vulnerable plaque: the pathology of unstable coronary lesions. J. Interv. Cardiol. 15, 439-446 (2002).
75. Libby, P. et al. Macrophages and atherosclerotic plaque stability. Curr. Opin. Lipidol. 7, 330-335 (1996).
76. Geng, Y. J. & Libby, P. Progression of atheroma: a struggle between death and procreation. Arterioscler. Thromb. Vasc. Biol. 22, 1370-1380 (2002).
77. Tabas, I. Apoptosis and plaque destabilization in atherosclerosis: the role of macrophage apoptosis induced by cholesterol. Cell Death Differ. 11 (Suppl. 1), S12-S16 (2004).
78. Schrijvers, D. M., De Meyer, G. R., Kockx, M. M., Herman, A. G. & Martinet, W. Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25, 1256-1261 (2005).
79. Tabas, I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis. The importance of lesion stage and phagocytic efficiency. Arterioscler. Thromb. Vasc. Biol. 25, 2255-2264 (2005).
80. Kockx, M. M. Apoptosis in the atherosclerotic plaque: quantitative and qualitative aspects. Arterioscler. Thromb. Vasc. Biol. 18, 1519-1522 (1998).
81. Nhan, T. Q., Liles, W. C. & Schwartz, S. M. Role of caspases in death and survival of the plaque macrophage. Arterioscler. Thromb. Vasc. Biol. 25, 895-903 (2005).
82. Li, Y. et al. Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids: implications for depletion of endoplasmic reticulum calcium stores and apoptosis in cholesterol-loaded macrophages. J. Biol. Chem. 279, 37030-37039 (2004).
83. Feng, B. et al. The endoplasmic reticulum is the site of cholesterol-induced cytotoxicity in macrophages. Nature Cell Biol. 5, 781-792 (2003).
84. Kaufman, R. J. Orchestrating the unfolded protein response in health and disease. J. Clin. Invest. 110, 1389-1398 (2002).
85. Feng, B. et al. Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis. Proc. Natl Acad. Sci. USA 100, 10423-10428 (2003).
86. Zhou, J., Lhotak, S., Hilditch, B. A. & Austin, R. C. Activation of the unfolded protein response occurs at all stages of atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 111, 1814-1821 (2005).
87. Li, Y. et al. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-α and interleukin-6: Model of NK-κB- and Map kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 280, 21763-21772 (2005).
88. Schroeder, F. Fluorescence probes in metastatic B16 melanoma membranes. Biochim. Biophys. Acta 776, 299-312 (1984).
89. Mo, H. & Elson, C. E. Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp. Biol. Med. 229, 567-585 (2004).
90. Vaughan, C. J. & Gotto, A. M. Jr. Update on statins: 2003. Circulation 110, 886-892 (2004).
91. Abad-Rodriguez, J. et al. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J. Cell Biol. 167, 953-960 (2004).
92. London, E. & Brown, D. A. Insolubility of lipids in Triton X-100: physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim. Biophys. Acta 1508, 182-195 (2000).
93. Huang, J. & Feigenson, G. W. A microscopic interaction model of maximum solubility of cholesterol in lipid bilayers. Biophys. J. 76, 2142-2157 (1999).
94. McConnell, H. M. & Radhakrishnan, A. Condensed complexes of cholesterol and phospholipids. Biochim. Biophys. Acta 1610, 159-173 (2003).
95. Brown, D. A. & London, E. Structure and origin of ordered lipid domains in biological membranes. J. Membr. Biol. 164, 103-114 (1998).
96. Feigenson, G. W. & Buboltz, J. T. Ternary phase diagram of dipalmitoyl-PC/dilauroyl-PC/cholesterol: nanoscopic domain formation driven by cholesterol. Biophys. J. 80, 2775-2788 (2001).
97. Megha & London, E. Ceramide selectively displaces cholesterol from ordered lipid domains (rafts): implications for lipid raft structure and function. J. Biol. Chem. 279, 9997-10004 (2004).
98. Wang, T. Y. & Silvius, J. R. Sphingolipid partitioning into ordered domains in cholesterol-free and cholesterol-containing lipid bilayers. Biophys. J. 84, 367-378 (2003).
99. Nakamura, K. et al. Expression and regulation of multiple murine ATP-binding cassette transporter G1 mRNAs/isoforms that stimulate cellular cholesterol efflux to high density lipoprotein. J. Biol. Chem. 279, 45980-45989 (2004).
100. Wang, N., Lan, D., Chen, W., Matsuura, F. & Tall, A. R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proc. Natl Acad. Sci USA 101, 9774-9779 (2004).